Frequency of colistin resistance in Pseudomonas aeruginosa: first report from Peru

Marjhory Zarate1, Delsy Barrantes1, Diego Cuicapuza2

  • 1Laboratorio de Resistencia Antimicrobiana e Inmunopatología, Universidad Peruana Cayetano Heredia, Lima, Perú.

Insights

Colistin resistance in Pseudomonas aeruginosa was found in 7.2% of clinical isolates from Lima, Peru. However, the mcr-1 gene, a common cause of resistance, was not detected in these resistant strains.

Area of Science:

  • Clinical microbiology
  • Antimicrobial resistance research
  • Infectious diseases

Background:

  • Colistin is a critical antibiotic for treating multidrug-resistant Gram-negative infections.
  • Pseudomonas aeruginosa is an opportunistic pathogen frequently associated with healthcare-associated infections.
  • Emergence of colistin resistance, particularly through the mcr-1 gene, is a significant global health concern.

Purpose of the Study:

  • To determine the prevalence of colistin resistance in Pseudomonas aeruginosa isolates from Peruvian healthcare facilities.
  • To investigate the presence of the mcr-1 gene in colistin-resistant Pseudomonas aeruginosa isolates.
  • To establish baseline data for antimicrobial resistance surveillance in Peru.

Main Methods:

  • Phenotypic detection of colistin resistance using the colistin broth disk elution method.
  • Detection of mcr-1 gene expression via phenotypic diffusion with colistin-EDTA disks.
  • Molecular confirmation of the mcr-1 gene using polymerase chain reaction (PCR).

Main Results:

  • Out of 97 Pseudomonas aeruginosa isolates, 7 (7.2%) exhibited resistance to colistin.
  • None of the colistin-resistant isolates harbored the mcr-1 gene.
  • This study represents the first report of colistin-resistant Pseudomonas aeruginosa clinical isolates in Peru.

Conclusions:

  • Colistin resistance in Pseudomonas aeruginosa exists in Peruvian clinical settings.
  • The absence of the mcr-1 gene in resistant isolates suggests alternative resistance mechanisms may be prevalent.
  • Enhanced surveillance strategies are crucial for monitoring colistin-resistant pathogens in Peru.